← FDA Drug Approvals (Drugs@FDA)
GRISACTIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WYETH AYERST · Approved 1972-06-20
Drug application
- FDA Application #
ANDA060212- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- GRISACTIN
- Generic name
- Griseofulvin, Microcrystalline
- Active ingredients
- GRISEOFULVIN, MICROCRYSTALLINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- WYETH AYERST
- First approval
- 1972-06-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown